RWA Wealth Partners’s Charles River Laboratories CRL Stock Holding History

RWA Wealth Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,630	Closed	-$385K	–	539
2023 Q4	$385K	Hold	1,630	–	–	0.01%	407
2023 Q3	$319K	Buy	+1,630	New	+$335K	0.01%	317
2023 Q2	–	Sell	-1,422	Closed	-$287K	–	334
2023 Q1	$287K	Hold	1,422	–	–	0.01%	213
2022 Q4	$351K	Hold	1,422	–	–	0.01%	206
2022 Q3	$280K	Hold	1,422	–	–	0.02%	203
2022 Q2	$304K	Hold	1,422	–	–	0.02%	188
2022 Q1	$404K	Sell	1,422 -18	-1%	-$5.55K	0.03%	185
2021 Q4	$543K	Buy	1,440 +18	+1%	+$6.99K	0.04%	163
2021 Q3	$587K	Hold	1,422	–	–	0.04%	156
2021 Q2	$526K	Hold	1,422	–	–	0.04%	161
2021 Q1	$412K	Hold	1,422	–	–	0.03%	175
2020 Q4	$355K	Hold	1,422	–	–	0.03%	179
2020 Q3	$322K	Hold	1,422	–	–	0.03%	167
2020 Q2	$248K	Buy	+1,422	New	+$227K	0.03%	189
2020 Q1	–	Sell	-1,422	Closed	-$217K	–	206
2019 Q4	$217K	Buy	+1,422	New	+$197K	0.02%	229
2019 Q3	–	Sell	-1,422	Closed	-$202K	–	232
2019 Q2	$202K	Hold	1,422	–	–	0.02%	222
2019 Q1	$207K	Buy	+1,422	New	+$187K	0.02%	219
2018 Q3	–	Sell	-1,422	Closed	-$160K	–	331
2018 Q2	$160K	Hold	1,422	–	–	0.02%	254
2018 Q1	$152K	Buy	+1,422	New	+$153K	0.02%	221

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

RWA Wealth Partners's CRL Position: Q1 2024 in Review

RWA Wealth Partners sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 1,630 shares — an estimated $385K sold.

RWA Wealth Partners first reported a position in CRL in Q1 2018 and held it in 19 quarters. The position peaked at $587K in Q3 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

RWA Wealth Partners reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
RWA Wealth Partners sold 1,630 Charles River Laboratories shares in Q1 2024, an estimated $385K.
RWA Wealth Partners first reported a position in Charles River Laboratories in Q1 2018 and held it in 19 quarters.
RWA Wealth Partners's Charles River Laboratories position peaked at $587K in Q3 2021.
676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on RWA Wealth Partners's 13F filing for Q1 2024, filed 29 Apr 2024.